Search

University of Exeter authors show, using Pseudomonas aeruginosa PA14 and phage DMS3vir, that antibiotics targeting protein translation raise CRISPR-Cas immunity against phages carrying anti-CRISPR (acr) genes by interfering with production

Raphael Hans wrote a new blog post on phage mediated biocontrol of phytopathogens for thephage.xyz.

National Geographic visited and wrote about Dr. Lillian Musila (Kenya Medical Research Institute) and her colleagues about their identification of over 150 phages and work toward using them to address AMR. The article features several Phage

Lucía Blasco and colleagues published a new paper describing 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and their potential use as typing markers and antimicrobial agents.

Hawkins et al. published a new paper which provides the first complete structural analysis of the S. epidermidis–infecting phage Andhra. Key findings include elucidating critical features for virion assembly, host recognition, and penetrati

The International Committee on Taxonomy of Viruses recently adopted a binomial naming format for virus species. A new paper describes how to create Latinized binomials for virus species, how to automatically generate large batches of novel

Steffanie Strathdee, Graham Hatfull, Vivek Mutalik and Robert Schooley wrote a new review of the state of the art in phage therapy, covering biological mechanisms, clinical applications, remaining challenges, and future directions.

The Ibadan Bacteriophage Research Team, an undergraduate SEA-PHAGES team at the University of Ibadan, Nigeria, announces the launch of the 2nd edition of the team’s journal issue, PHAMILIA. This is the very first undergraduate research jour

Exciting day 🤩 Our newly born GIVoM - Gruppo Italiano Virus of Microbes met for the first time! Italians – in the country and abroad 🇮🇹 - working in this field 🧫🦠🧬 will gather every month to share our research and support each other.❗

Technophage, a phage biotech company in Portugal, successfully completed its Phase I/IIa Clinical Trial of TP-102, a phage cocktail for infected diabetic foot ulcers.

The Antibacterial Resistance Leadership Group will begin a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial to examine safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized

From 2018 to 2022, IPATH initiated phage hunts for 265 patients, but 25% couldn't proceed due to lack of phages. IPATH has now partnered with Korean phage company MicrobiotiX; IPATH will screen and send sample isolates to MicrobiotiX, who w

Cole Matrishin (University at Buffalo) and colleagues published a new preprint on how phages are unrecognized players in oral pathogen Porphyromonas gingivalis ecology, contributing to strain-level diversity and the species pangenome. They

In a new GARDP antimicrobial viewpoint piece, Jon Iredell and Jessica Sacher of Phage Australia discuss ways to improve the economics of personalized phage therapy as part of a clinical service, including increasing the number of patients w

The Ibadan Bacteriophage Research Team, an undergraduate SEA-PHAGES team at the University of Ibadan, Nigeria, announces the launch of the 2nd edition of the team’s journal issue, PHAMILIA. This is the very first undergraduate research jour

Steffanie Strathdee, Graham Hatfull, Vivek Mutalik and Robert Schooley wrote a new review of the state of the art in phage therapy, covering biological mechanisms, clinical applications, remaining challenges, and future directions.

University of Nebraska-Lincoln authors show that small protists can consume viruses and grow and divide given only viruses to eat; the ciliate Halteria sp. foraging on chloroviruses shows dynamics similar to other microbial trophic interact

Fixed Phage, a biotechnology company based in Glasgow, has secured £1.5 million in funding to further develop and commercialize its phage technology.

The Phage Australia Clinical Network has published the STAMP Protocol for phage therapy. This is an open-label, single-arm trial investigating a standardised treatment and monitoring protocol for phage therapy. The aim is to recruit 50–100

In a new study published in Frontiers in Cellular and Infection Microbiology, Sheetal Patpatia (University of Helsinki) and colleagues describe how they set up a rapid hydrogel-based liquid phage susceptibility assay (PST) for the selection